Rare Allergic Respiratory Diseases
Rare allergic respiratory disorders are sporadic airway diseases that are the result of the body’s hypersensitivity to allergens from the environment. These all produce ongoing breathing problems – chronic coughing, difficulty breathing, etc. And sometimes they’re accompanied by underlying symptoms such as fatigue and weight gain. Protheragen’s specialty is new diagnostics and treatments that solve and help your research needs for rare allergic respiratory diseases as quickly as possible.
Classification of Rare Allergic Respiratory Diseases
-
Hypersensitivity Pneumonitis
This rarely encountered immune-mediated lung disease arises when exposure to organic dusts leads to inflammation. The most common symptoms are cough, shortness of breath, and derangements such as weight loss and weakness. It can occur suddenly or get worse as you are exposed.
-
Allergic Bronchopulmonary Aspergillosis (ABPA)
An immune response to Aspergillus fumigatus causes it and typically occurs in patients with asthma or cystic fibrosis. Uncontrolled asthma, coughing, and frequent lung infections are symptoms. It can permanently damage your lung if not treated, typically with antifungal and corticosteroid medications.
-
Idiopathic Chronic Eosinophilic Pneumonia
This deadly lung disease causes breathlessness, coughing, and wheezing, and can look and act like other respiratory disorders. It involves increased eosinophils in the lungs, and corticosteroids to control inflammation and symptoms (especially for those who’ve had asthma in the past).
Our Services
At Protheragen, we’re passionate about pioneering drug discovery, specifically for rare allergic respiratory diseases. Our dedicated team excels in innovative technologies and procedures, ensuring swift drug development. We customize our solutions to tackle the unique challenges of researching these rare conditions, always striving to make a meaningful impact.
By Molecule Type
By Research Phase
Our Rare Allergic Respiratory Diseases Model Development Services
At Protheragen, we’re masters at modeling uncommon allergic respiratory conditions in order to capture their complexities and therapy pathways. These models are invaluable in rare diseases studies where we can test whether new therapies are safe and effective, which translates into faster development.
In Vitro Models
Our in vitro models enable detailed exploration of cellular behaviors and drug efficacy in rare allergic respiratory diseases, aiding in the identification of potential therapeutic targets and understanding disease mechanisms.
- 3D Bioprinting Models
- Organ-on-a-Chip Models
- Spheroids
- Microfluidic Cell Culture
- Organoid Models
In Vivo Models
Our in vivo models provide a holistic view of rare allergic respiratory diseases, supporting the evaluation of treatment strategies and offering insights into disease progression and systemic therapeutic responses.
- Genetically Engineering Model
- Induced Disease Model
- Humanized Animal Model
- Syngeneic Model
- Xenograft Model
With extensive expertise in rare disease R&D services, our company offers comprehensive support, ensuring swift responses to evolving research needs. We provide professional communication and assistance, from disease model development to innovative therapy research. For more details and quotation information, please contact us .
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.